Organisation paid for research Program year 2021 Source: CMS Open Payments

Pautler Scott

Neither a doctor nor a teaching hospital

Research payments

$4,738,065

262 payments

Through program year 2021, Pautler Scott is reported as receiving $4,738,065 in research payments, across 262 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$1,798,434	90
2020	Research	$1,981,316	116
2019	Research	$958,316	56

Breakdown

Who paid Research payments · program years 2019–2021

Genentech, Inc. $4,487,737 233 payments
Roche TCRC, Inc. $250,328 29 payments

Studies the money was for Research payments · program years 2019–2021

Va2 Phiii $1,180,760 37 payments
Port Delivery System for Ranibizumab $714,956 34 payments
Va2 Phiii Rhine $678,985 37 payments
Port Delivery System of Ranizibumab Extension Study $663,779 32 payments
Port Delivery System of Ranibizumab Extension Study $315,364 8 payments
Faricimab Dme Long Term Extension Rhone X $241,129 10 payments
Lucentis Fsv4 Lad Amd Ladder $222,215 37 payments
Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $169,650 14 payments
Ro7200220 for Diabetic MacUlar Edema $134,055 12 payments
Phase 2 of Ro7171009 in Ga $116,702 10 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.